MOTS-c
Metabolic Research only Animal studies
Also called Mitochondrial ORF of the 12S rRNA type-c
A 16-amino-acid peptide encoded in mitochondrial DNA. It acts like a hormone, activating the energy sensor AMPK and improving how muscle uses glucose. In mice it countered diet-induced obesity and insulin resistance and improved exercise capacity, and levels rise with exercise in people.
Evidence at a glance
- Evidence
- Animal studies — Not yet studied in people
- Status
- Research compound only
- Dosing
- No human study has set a dose
The human side is observational. No trials of giving MOTS-c to people.
What studies report
- Prevented diet-induced obesity and insulin resistance in mice
- Improved exercise capacity and muscle glucose use in rodents
- Natural levels rise with exercise and fall with age in people
How it works
Encoded inside mitochondrial DNA. Acts on metabolism — reported to raise ATP production during exercise and shift white fat toward brown fat.
Where it acts
PancreasThe library groups this compound under Metabolic. The diagram shows that target, not every tissue it reaches.
Illustrated

AI-generated subject illustration; not a depiction of the compound or evidence of its effects.
Why people take it
Reasons people seek it out — not a list of proven effects.
In practice Unapproved use
- Run in cycles timed around training blocks rather than continuously
- Often stacked with NAD+ and 5-Amino-1MQ as a metabolic combination
- Popular with endurance athletes for perceived aerobic capacity
Reported real-world use, not evidence and not a recommendation.
Dosing
No human study has established a dose for this compound.
What people report using Not evidence
- 5–10 mg weekly is commonly cited
- Cycled around training blocks rather than taken continuously
No human administration trials exist. Natural levels have been measured in people, which is not the same thing.
Reported for reference, not as instruction. Nothing here is a recommendation to take anything, and most of these compounds are not approved for human use.
Status: Mostly animal research. Not approved.
- Route
- Subcutaneous injection, from reconstituted lyophilised powder
- Sequence
- Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
- Formula
- C101H152N28O22S2
- Molecular weight
- 2174.6 g/mol
- CAS
- 1627580-64-6
- Available as
- 10 mg, 20 mg, 40 mg
Search PubMed for MOTS-c → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.
Compared with
Side-by-side pages for the compounds this one is most often confused with or taken alongside.
Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.